Beasley - When I first read your note, I thought m
Post# of 36536
"Generex Biotechnology CEO Joe Moscato said: 'Pantheon not only adds immediate revenues and profits to the NuGenerex family of companies, but also brings significant upside opportunities for new FDA-approved product introductions over the next several years.'"
https://www.medicaldevice-network.com/news/ge...n-medical/
Funny how I don't recall us ever seeing any report of that "immediate revenue and profits."
Amazing thing, the inter-web; it just keeps on giving and giving.
Anyway, have a great weekend.We here in the mid-Atlantic have a nice layer of white to enjoy.